| LIXT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LIXT market cap history going back to 11/20/2020:
Also see: LIXT Shares Outstanding History and LIXT YTD Return |
As of 5/12/2026 Lixte Biotechnology Holdings has a market cap of 62.78 million. Investors often follow the LIXT market cap history to compare the size of the company over time.
This page shows LIXT market capitalization trends over time, with 21 market cap datapoints presented, dating back to 11/20/2020.

| LIXT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LIXT market cap history going back to 11/20/2020:
Also see: LIXT Shares Outstanding History and LIXT YTD Return |
| LIXT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||
LIXT Historical Market Cap: -0.80% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| LIXT Stock Price Chart |
| About Lixte Biotechnology Holdings, Inc. |
| Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. Co.'s product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers. Co. encompasses that inhibitors of protein phosphatases have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. It is focused on development activities of its LB-100 series of drugs. We show 21 historical shares outstanding datapoints in our LIXT shares outstanding history coverage, used to compute LIXT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LIXT market cap history over the course of time is important for investors interested in comparing LIXT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LIXT versus a peer is one thing; comparing LIXT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LIXT can fluctuate over the course of history. With this page we aim to empower investors researching LIXT by allowing them to research the LIXT market cap history. |
| LIXT Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| LIXT Share Performance |
| Market Cap Peers |
| Lixte Biotechnology Holdings (LIXT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
LJPC Market Cap History LLY Market Cap History LMAT Market Cap History LMNX Market Cap History LNSR Market Cap History LNTH Market Cap History LONA Market Cap History LOXO Market Cap History LPCN Market Cap History LPNT Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.